ACER
Closed
Acer Therapeutics Inc
0.6601
-0.1444 (-17.95%)
Last Update: 21 Nov 2023 00:00:00
Yesterday: 0.8045
Day's Range: 0. - 0.
Send
sign up or login to leave a comment!
When Written:
0.7511
Acer Therapeutics Inc is a pharmaceutical company that specializes in developing therapies for rare and life-threatening diseases. The company was founded in 2017 and is headquartered in Newton, Massachusetts.
Acer Therapeutics focuses on developing drugs for serious diseases that have limited treatment options. The company's lead drug candidate is Edsivo, which is being developed for the treatment of vascular Ehlers-Danlos syndrome (vEDS), a rare genetic disorder that affects the connective tissue in the body.
In addition to Edsivo, Acer Therapeutics is also developing other drug candidates for the treatment of rare diseases, including ACER-001 for the treatment of urea cycle disorders and ACER-801 for the treatment of maple syrup urine disease.
Acer Therapeutics is a publicly traded company on the NASDAQ stock exchange under the ticker symbol ACER. The company has partnerships with various organizations, including the National Organization for Rare Disorders (NORD) and the Genetic and Rare Diseases Information Center (GARD).
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Acer Therapeutics focuses on developing drugs for serious diseases that have limited treatment options. The company's lead drug candidate is Edsivo, which is being developed for the treatment of vascular Ehlers-Danlos syndrome (vEDS), a rare genetic disorder that affects the connective tissue in the body.
In addition to Edsivo, Acer Therapeutics is also developing other drug candidates for the treatment of rare diseases, including ACER-001 for the treatment of urea cycle disorders and ACER-801 for the treatment of maple syrup urine disease.
Acer Therapeutics is a publicly traded company on the NASDAQ stock exchange under the ticker symbol ACER. The company has partnerships with various organizations, including the National Organization for Rare Disorders (NORD) and the Genetic and Rare Diseases Information Center (GARD).
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!